Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents ( de but are not limited to risksassoc...)

HOME >> MEDICINE >> TECHNOLOGY

Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents

de, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development, manufacturing and commercialization; the impact of competitive products, including, but not limited to the impact of those on Shire's Attention Deficit and Hyperactivity Disorder ("ADHD") franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval dates of SPD503 (guanfacine extended release) (ADHD) and SPD465 (extended release triple-bead mixed amphetamine salts) (ADHD); Shire's ability to secure new products for commercialization and/or development; Shire's ability to benefit from its acquisition of New River Pharmaceuticals Inc.; and other risks and uncertainties detailed from time to time in Shire plc's filings with the Securities and Exchange Commission, particularly Shire plc's Annual Report on Form 10-K for the year ended December 31, 2006.

CONTACT: Marion E. Glick, +1-212-601-8273, +1-917-301-4206, on site atAPA, or Debra Gemme, +1-212-601-8342, +1-703-298-4030, on site at APA, bothfor Shire plc

Web site: http://www.shire.com/

Ticker Symbol: (NASDAQ-NMS:SHPGY),(Toronto:SHQ.)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company

Page: 1 2 3 4 5 6 7 8
Related medicine technology :

1. Shire to Present New Scientific Data on ADHD Treatment Portfolio at APA Annual Meeting
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:

(Date:11/20/2009)... , NEW YORK, Nov. 20 Rep... report is available in its catalogue. ,, Bloo...s - A World Market Analysis ,, http://www.re...-Measurement-Instruments---A-World-Market-Analysis...utm_campaign=prnewswire ,, Measurement of blo...

(Date:11/20/2009)... , NEW YORK, Nov. 20 Rep... report is available in its catalogue. ,, Pipe... ,, http://www.reportlinker.com/p0164373/Pip...l#utm_source=prnewswire&utm_medium=pr&utm_... are treated as an integral part of any research l...

(Date:11/20/2009)... , NEW YORK, Nov. 20 ,...search report is available in its catalogue. ,,..., http://www.reportlinker.com/p0164741/Global...ource=prnewswire&utm_medium=pr&utm_campaig... biopsy devices includes the spring loaded core ne...

[0] Reportlinker Adds Blood Pressure Monitoring & Measurement Instruments - A World Market Analysis [0] Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective [0] Reportlinker Adds Global Markets for Breast Biopsy Devices 2009

...ational Team of Athletes ...thers with Diabetes and Steers Toward Its ... BRIDGEWATER, N.J., April 2, 2008 ,Sanofi-aventis ... (insulin,glulisine [rDNA origin] injection) will ...eam of amateur and professional cyclists living wi...

...ty infusion continues funding CoAxia,s studies of ...Therapy for Ischemic Stroke, MINNEAPOLIS, April 1... announced the closing of an additional $11.5M fin...nuation of CoAxia,s ongoing,clinical trials. The i...ced,C Round and will allow CoAxia to continue its ...

Other Medicine Technology:Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 2 Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 3 Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 4 Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 5 CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors 2

Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)CoAxia(TM) Announces $11.5M Equity Financing From Existing Investors

(Date:11/21/2009)... New Haven Dental Group merge....D.S of Branford, CT. , (...roup, comprised of partners Dr. David Gibson, Dr. ...orrester has just merged their growing practice wi...n., , ,When Dr. Pickman decided he wanted to retir...

(Date:11/20/2009)... , PRINCETON, NJ, Nov. 20 /PRNewswire-FirstCa...y that a Special Meeting of Shareholders will be h...he Meeting is to consider approval of two special ...prove and authorize the sale of all or substantial...the terms provided for in the asset purchase agree...

(Date:11/20/2009)... , QUINCY, Mass., Nov. 20 Foll...ermarket Company removed from sale Shedd,s Country...Rice and Shedd,s Country Crock ® Side Dishes ...ite allergen. ,, The following code dates and ...174; Side Dishes DELUXE Cheddar Broccoli Rice 21 o...

(Date:11/20/2009)... , CHICAGO, Nov. 20 ... the U.S. Food and Drug Administration (FDA) to es...ening chemicals. ,, Citing concern about the s...tered without the benefit of professional consulta...said that the application of chemically based toot...

(Date:11/20/2009)... , WINSTON-SALEM, N.C., Nov. 20 /PRNewswire-US... is on a mission to redefine what it means to be "...onal counselor with a specialty in family counseli...ke Forest University, Gladding says research shows...ads to sadness and even depression during the holi...

Breaking Medicine News(10 mins):Health News:New Haven Dental Group Expands Their Vision 2 Health News:NUCRYST Announces Special Meeting of Shareholders 2 Health News:NUCRYST Announces Special Meeting of Shareholders 3 Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2 Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2 Health News:Why Holidays Don't Have To Be 'Happy' 2

[0] New Haven Dental Group Expands Their Vision [0] NUCRYST Announces Special Meeting of Shareholders [0] Stop & Shop Alerts Customers to Voluntary Recall by Unilever [0] American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products [0] Why Holidays Don't Have To Be 'Happy'

...agada SubbaRow, an Indian from Andhra Pradesh in t...S in biochemistry, helping to bring to humankind ...he admirers of Yellapragada SubbaRow, a name very ...arch at US pharma giant Lederle Laboratories in th...

...e is at least six years away for talented actress ...listing out the qualities she wants in Mr.Right! ...o I've a good six years to find Mr. Right," Kangan...turer with a steady income. He should be intellige...

...rsons can no longer remain complacent assuming the... British researchers caution that thin people may...ls team has conducted extensive research involving...ternal fat gathering around vital organs. ...

...e is a hot topic in the presidential elections in ... . And they dont allow politicians to get ...er George Smitherman was waxing eloquent on the go...bearing the slogans "Cancer patients need a credit...

...s widespread disgust and outrage expressed over th... partners-in crime; homosexual lovers Robbie Sebas... Urquhart, 46, have been placed together in Hakea ...as rescued. The pair had even plotted to murder th...

...ome African-American high school students with ast...based disease management program reported fewer da...ssed, fewer days of restricted activity, and less ...P.H, Ph.D., Senior Staff Epidemiologist for the He...

Other Medicine News:Health News:The Forgotten Indian Medical Genius 2 Health News:The Forgotten Indian Medical Genius 3 Health News:Gentle, Real, Well-mannered - Kangana's Mr. Right 2 Health News:Thin People may Be Internally Fat 2 Health News:Cancer Patients Turn Their Backs on Canadian Health Minister 2 Health News:Outrage Against Gay PartnersInCrime Kept Together 2 Health News:Web-based Asthma Program Improves Disease Management for Black Students 2

The Forgotten Indian Medical Genius Gentle, Real, Well-mannered - Kangana's Mr. Right Thin People may Be Internally Fat Cancer Patients Turn Their Backs on Canadian Health Minister Outrage Against Gay PartnersInCrime Kept Together Web-based Asthma Program Improves Disease Management for Black Students

Magic WALLSTENT® Stent System

Finnpipette Focus 12 channel, 1-10uL, micro

Finnpipette Digital Multichannel, 12 channel 0.5-10ul

Corning 12-Pette, 20-200 ul, 1-12 Channels

Medicine Products:

Magic WALLSTENT® Stent System Finnpipette Focus 12 channel, 1-10uL, micro Finnpipette Digital Multichannel, 12 channel 0.5-10ul Corning 12-Pette, 20-200 ul, 1-12 Channels

( de but are not limited to risksassoc...)Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents,Health